{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:42:17Z","timestamp":1773243737887,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T00:00:00Z","timestamp":1670025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009099","name":"Reinholdt W. Jorck og Hustrus Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Knud H\u00f8jgaard Fonden"},{"DOI":"10.13039\/501100015626","name":"Melanoma Institute Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015626","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1245\/s10434-022-12840-2","type":"journal-article","created":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:03:18Z","timestamp":1670112198000},"page":"2354-2361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma"],"prefix":"10.1245","volume":"30","author":[{"given":"Trine","family":"Schoenfeldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serigne","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof T.","family":"Drzewiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Stretch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn P. M.","family":"Saw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerwin","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger F.","family":"Uren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette H.","family":"Chakera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omgo E.","family":"Nieweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,3]]},"reference":[{"key":"12840_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMe1313690","volume":"370","author":"CM Balch","year":"2014","unstructured":"Balch CM, Gershenwald JE. Clinical value of the sentinel-node biopsy in primary cutaneous melanoma. N Engl J Med. 2014;370:663\u20134.","journal-title":"N Engl J Med."},{"key":"12840_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"JE Gershenwald","year":"1999","unstructured":"Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17:976\u201383.","journal-title":"J Clin Oncol."},{"key":"12840_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1046\/j.1365-2168.2000.01362.x","volume":"87","author":"L Jansen","year":"2000","unstructured":"Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Vald\u00e9s Olmos RA, Kroon BBR. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg. 2000;87:484\u20139.","journal-title":"Br J Surg."},{"key":"12840_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med."},{"key":"12840_CR5","first-page":"892","volume":"377","author":"MB Faries","year":"2017","unstructured":"Faries MB, Cochran AJ, Thompson JF. Melanoma sentinel-node metastasis. N Engl J Med. 2017;377:892.","journal-title":"N Engl J Med."},{"key":"12840_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17:757\u201367.","journal-title":"Lancet Oncol."},{"key":"12840_CR7","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377:1813\u201323.","journal-title":"N Engl J Med."},{"key":"12840_CR8","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377:1824\u201335.","journal-title":"N Engl J Med."},{"key":"12840_CR9","first-page":"570","volume":"44","author":"RF Uren","year":"2003","unstructured":"Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med. 2003;44:570\u201382.","journal-title":"J Nucl Med."},{"key":"12840_CR10","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/1346-8138.12831","volume":"42","author":"Y Kaneko","year":"2015","unstructured":"Kaneko Y, Asai J, Wada M, et al. The triangular intermuscular space: an uncommon sentinel node location in melanoma of the upper arm. J Dermatol. 2015;42:548\u201350.","journal-title":"J Dermatol."},{"key":"12840_CR11","first-page":"964","volume":"37","author":"RF Uren","year":"1996","unstructured":"Uren RF, Howman-Giles R, Thompson JF, et al. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med. 1996;37:964\u20136.","journal-title":"J Nucl Med."},{"key":"12840_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1245\/s10434-013-3285-y","volume":"21","author":"C Carac\u00f2","year":"2014","unstructured":"Carac\u00f2 C, Marone U, Di Monta G, et al. Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma. Ann Surg Oncol. 2014;21:300\u20135.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-2168.2001.01676.x","volume":"88","author":"GK Roozendaal","year":"2001","unstructured":"Roozendaal GK, de Vries JD, van Poll D, et al. Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg. 2001;88:305\u20138.","journal-title":"Br J Surg."},{"key":"12840_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1245\/ASO.2003.01.023","volume":"10","author":"SH Estourgie","year":"2003","unstructured":"Estourgie SH, Nieweg OE, Vald\u00e9s Olmos RA, Hoefnagel CA, Kroon BBR. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol. 2003;10:681\u20138.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR15","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1245\/s10434-010-1018-z","volume":"17","author":"SA Hennessy","year":"2010","unstructured":"Hennessy SA, Dengel LT, Hranjec T, Slingluff CL Jr. A triangular intermuscular space sentinel node in melanoma: association with axillary lymphatic drainage. Ann Surg Oncol. 2010;17:2465\u201370.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/SAP.0b013e31819b6c87","volume":"64","author":"GS Herbert","year":"2010","unstructured":"Herbert GS, Beshlian KM. The triangular intermuscular space as a site of lymph node metastasis in melanoma of the back. Ann Plast Surg. 2010;64:52\u20134.","journal-title":"Ann Plast Surg."},{"key":"12840_CR17","doi-asserted-by":"publisher","first-page":"179S","DOI":"10.1245\/ASO.2004.11.916","volume":"11","author":"RF Uren","year":"2004","unstructured":"Uren RF. Lymphatic drainage of the skin. Ann Surg Oncol. 2004;11:179S-S185.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1053\/j.seminoncol.2004.03.007","volume":"31","author":"RF Uren","year":"2004","unstructured":"Uren RF, Howman-Giles R, Chung D, Thompson JF. Nuclear medicine aspects of melanoma and breast lymphatic mapping. Semin Oncol. 2004;31:338\u201348.","journal-title":"Semin Oncol."},{"key":"12840_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/0-387-23604-X_2","volume":"127","author":"RF Uren","year":"2005","unstructured":"Uren RF, Howman-Giles RB, Chung D, Thompson JF. Role of lymphoscintigraphy for selective sentinel lymphadenectomy. Cancer Treat Res. 2005;127:15\u201338.","journal-title":"Cancer Treat Res."},{"key":"12840_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1470-2045(05)70423-X","volume":"6","author":"JF Thompson","year":"2005","unstructured":"Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol. 2005;6:877\u201385.","journal-title":"Lancet Oncol."},{"key":"12840_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1072-7515(99)00108-8","volume":"189","author":"JF Thompson","year":"1999","unstructured":"Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 1999;189:195\u2013204.","journal-title":"J Am Coll Surg."},{"key":"12840_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s10434-001-0538-y","volume":"8","author":"OE Nieweg","year":"2001","unstructured":"Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538\u201341.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/978-3-319-40618-3_47","volume":"8","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma of the skin. AJCC Cancer Staging Manual. 2017;8:563\u201385.","journal-title":"AJCC Cancer Staging Manual."},{"key":"12840_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/00000478-200309000-00002","volume":"27","author":"LX Li","year":"2003","unstructured":"Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197\u2013202.","journal-title":"Am J Surg Pathol."},{"key":"12840_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0748-7983(98)93428-X","volume":"24","author":"OE Nieweg","year":"1998","unstructured":"Nieweg OE, Jansen L, Kroon BBR. Technique of lymphatic mapping and sentinel node biopsy for melanoma. Eur J Surg Oncol. 1998;24:520\u20134.","journal-title":"Eur J Surg Oncol."},{"key":"12840_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jso.21770","volume":"104","author":"RF Uren","year":"2011","unstructured":"Uren RF, Howman-Giles R, Chung D, Thompson JF. Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma. J Surg Oncol. 2011;104:405\u201319.","journal-title":"J Surg Oncol."},{"key":"12840_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/CMR.0b013e328308da77","volume":"18","author":"AH Chakera","year":"2008","unstructured":"Chakera AH, Hansen LB, Lock-Andersen J, Drzewiecki KT, Hesse B. In-transit sentinel nodes must be found: implication from a 10-year follow-up study in melanoma. Melanoma Res. 2008;18:359\u201364.","journal-title":"Melanoma Res."},{"issue":"9","key":"12840_CR28","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.ejso.2019.03.026","volume":"45","author":"AA Nijhuis","year":"2019","unstructured":"Nijhuis AA, Ivan Filho D, Uren RF, Thompson JF, Nieweg OE. Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients. Eur J Surg Oncol. 2019;45(9):1706\u201311.","journal-title":"Eur J Surg Oncol"},{"key":"12840_CR29","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1245\/s10434-019-07505-6","volume":"26","author":"NA Ipenburg","year":"2019","unstructured":"Ipenburg NA, Thompson JF, Uren RF, Chung D, Nieweg OE. Focused ultrasound surveillance of lymph nodes following lymphoscintigraphy without sentinel node biopsy: a useful and safe strategy in elderly or frail melanoma patients. Ann Surg Oncol. 2019;26:2855\u201363.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1245\/s10434-016-5458-y","volume":"24","author":"NA Ipenburg","year":"2017","unstructured":"Ipenburg NA, Nieweg OE, Uren RF, Thompson JF. Outcome of melanoma patients who did not proceed to sentinel node biopsy after preoperative lymphoscintigraphy. Ann Surg Oncol. 2017;24:117\u201326.","journal-title":"Ann Surg Oncol."},{"key":"12840_CR31","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307\u201317.","journal-title":"N Engl J Med."},{"issue":"9","key":"12840_CR32","first-page":"835","volume":"157","author":"JS Crystal","year":"2022","unstructured":"Crystal JS, Thompson JF, Hyngstrom J, et al. Therapeutic value of sentinel lymph node biopsy in patients with melanoma: a randomized clinical trial. JAMA Surg. 2022;157(9):835\u201342.","journal-title":"JAMA Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12840-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12840-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12840-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T10:03:47Z","timestamp":1679306627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12840-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["12840"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12840-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,3]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"John F. Thompson has received honoraria for advisory board participation from BMS Australia, MSD Australia, GSK, and Provectus Inc, as well as travel and conference support from GSK, Provectus Inc, and Novartis. Robyn P. M. Saw has received honoraria for advisory board participation from MSD, Novartis, and Qbiotics and speaking honoraria from BMS and Novartis. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}